These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25983374)

  • 1. Altered chromogranin A circulating levels in Meniere's disease.
    Teggi R; Colombo B; Trimarchi M; Bianco M; Manfredi A; Bussi M; Corti A
    Dis Markers; 2015; 2015():643420. PubMed ID: 25983374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors.
    Kitahara T; Doi K; Maekawa C; Kizawa K; Horii A; Kubo T; Kiyama H
    J Neuroendocrinol; 2008 Dec; 20(12):1295-300. PubMed ID: 19094077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack.
    Aoki M; Asai M; Nishihori T; Mizuta K; Ito Y; Ando K
    J Neuroendocrinol; 2007 Nov; 19(11):901-6. PubMed ID: 17927668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study.
    Bachetti T; Ferrari Bardile A; Aloi TL; Colombo B; Assi E; Savino G; Vercelli A; Colombo R; Corti A
    Int J Cardiol; 2017 Jun; 236():438-443. PubMed ID: 28190616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients.
    Atrache Al Attrache N; Krstulovic C; Pérez Guillen V; Morera Pérez C; Pérez Garrigues H
    J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray analysis of stress-related gene expression in patients with Ménière's disease.
    Sekine K; Morita K; Masuda K; Sato G; Rokutan K; Takeda N
    ORL J Otorhinolaryngol Relat Spec; 2005; 67(5):294-9. PubMed ID: 16374063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-third of vertiginous episodes during the follow-up period are caused by benign paroxysmal positional vertigo in patients with Meniere's disease.
    Taura A; Funabiki K; Ohgita H; Ogino E; Torii H; Matsunaga M; Ito J
    Acta Otolaryngol; 2014 Nov; 134(11):1140-5. PubMed ID: 25166020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endolymphatic duct blockage: a randomized controlled trial of a novel surgical technique for Ménière's disease treatment.
    Saliba I; Gabra N; Alzahrani M; Berbiche D
    Otolaryngol Head Neck Surg; 2015 Jan; 152(1):122-9. PubMed ID: 25403881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Ménière's disease by intratympanic gentamicin application.
    Assimakopoulos D; Patrikakos G
    J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical observation on acute low-frequency hearing loss without vertigo: the role of cochlear hydrops analysis masking procedure as initial prognostic parameter.
    Hong SK; Nam SW; Lee HJ; Koo JW; Kim DH; Kim DR; Kim H
    Ear Hear; 2013; 34(2):229-35. PubMed ID: 22976344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in audiometric thresholds before, during and after attacks of vertigo associated with Meniere's syndrome.
    McNeill C; Cohen MA; Gibson WP
    Acta Otolaryngol; 2009 Dec; 129(12):1404-7. PubMed ID: 19922089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of the plasma vasopressin level during attacks with a prognosis of Meniere's disease.
    Aoki M; Hayashi H; Kuze B; Mizuta K; Ito Y
    Int J Audiol; 2010 Jan; 49(1):1-6. PubMed ID: 20053151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of antidiuretic hormone levels with an attack of Meniere's disease.
    Aoki M; Ando K; Kuze B; Mizuta K; Hayashi T; Ito Y
    Clin Otolaryngol; 2005 Dec; 30(6):521-5. PubMed ID: 16402977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antidiuretic hormone levels in patients with unilateral Meniere's disease.
    Lim JS; Lange ME; Megerian CA
    Laryngoscope; 2003 Aug; 113(8):1321-6. PubMed ID: 12897553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of vertigo recurrences in Meniere's disease by the head-shaking test.
    Kamei T; Iizuka T
    Int Tinnitus J; 1999; 5(1):47-9. PubMed ID: 10753419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proteomics-driven assay defines specific plasma protein signatures in different stages of Ménière's disease.
    Chiarella G; Di Domenico M; Petrolo C; Saccomanno M; Rothenberger R; Giordano A; Costanzo F; Cassandro E; Cuda G
    J Cell Biochem; 2014 Jun; 115(6):1097-100. PubMed ID: 24356812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life instruments in Ménière's disease.
    Green JD; Verrall A; Gates GA
    Laryngoscope; 2007 Sep; 117(9):1622-8. PubMed ID: 17667131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of IgG auto-antibodies, anti-collagen type II specific in Menière's disease and progressive hearing loss].
    Muiño JC; Carreras R; Ocampo MA; Ferrero M; Romero Piffiguer MD; Landa C; Beltramo D
    Rev Fac Cien Med Univ Nac Cordoba; 1999; 56(2):71-80. PubMed ID: 10883508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.